AIFF
Firefly Neuroscience, Inc.
Price Chart
Latest Quote
$1.58
-0.13 (-7.60%)
Current Price
| Previous Close | $1.71 |
| Open | $1.72 |
| Day High | $1.72 |
| Day Low | $1.55 |
| Volume | 292,934 |
Stock Information
| Shares Outstanding | 15.57M |
| Cash Equivalents | $3.13M |
| Revenue | $1.58M |
| Net Income | $-17.93M |
| Sector | Technology |
| Industry | Software - Application |
| Market Cap | $24.60M |
| EPS (TTM) | $-0.36 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $21.48M |
| Sales | $1.58M |
| Income | $-17.93M |
| Book/sh | $0.57 |
| Cash/sh | $0.20 |
| Employees | 17 |
Financial Ratios
| Quick Ratio | 1.35 |
| Current Ratio | 1.82 |
Returns & Margins
| ROA | -45.65% |
| ROE | -131.44% |
| Gross Margin | 51.96% |
| Operating Margin | -414.43% |
Ownership
| Insider Ownership | 28.00% |
| Institutional Ownership | 7.88% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 15.53 |
| P/B | 2.78 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.73 |
| SMA50 | $1.90 |
| SMA200 | $1.80 |
| RSI | 42.31 |
| ATR | 0.1164 |
| Shares Float | 13.58M |
| Short Float | 6.84% |
| Short Ratio | 1.23 |
| Rel Volume | 0.78 |
Performance History
| Week | -10.73% |
| Month | -18.13% |
| Quarter | -14.59% |
| 6 Months | -4.82% |
| YTD | +77.53% |
| Year | -52.12% |
| 3 Years | -85.77% |
| 5 Years | -97.89% |
| 10 Years | -67.08% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $1.58 | 302,300 |
| 2026-06-04 | $1.71 | 191,100 |
| 2026-06-03 | $1.65 | 351,400 |
| 2026-06-02 | $1.78 | 3,346,600 |
| 2026-06-01 | $1.71 | 209,600 |
| 2026-05-29 | $1.77 | 175,100 |
| 2026-05-28 | $1.80 | 185,400 |
| 2026-05-27 | $1.73 | 215,200 |
| 2026-05-26 | $1.69 | 178,500 |
| 2026-05-22 | $1.75 | 167,200 |
| 2026-05-21 | $1.71 | 187,400 |
| 2026-05-20 | $1.68 | 282,900 |
| 2026-05-19 | $1.66 | 135,400 |
| 2026-05-18 | $1.66 | 227,900 |
| 2026-05-15 | $1.70 | 324,500 |
| 2026-05-14 | $1.78 | 439,500 |
| 2026-05-13 | $1.80 | 176,900 |
| 2026-05-12 | $1.80 | 198,900 |
| 2026-05-11 | $1.80 | 276,000 |
| 2026-05-08 | $1.89 | 210,700 |
| 2026-05-07 | $1.90 | 356,100 |
| 2026-05-06 | $1.93 | 382,000 |
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $497,000 | $0 | - | $0 |
| Cost Of Revenue | $497,000 | $0 | - | $0 |
| Total Revenue | $1,142,000 | $108,000 | $498,000 | $0 |
| Operating Revenue | $1,109,000 | $108,000 | $478,000 | $0 |
| Expenses | ||||
| Interest Expense | $159,000 | $69,000 | $18,000 | $574,000 |
| Total Expenses | $9,747,000 | $9,288,000 | $3,576,000 | $3,252,000 |
| Other Income Expense | $-11,202,000 | $-1,209,000 | $494,000 | $37,000 |
| Other Non Operating Income Expenses | $-224,000 | $-190,000 | $457,000 | $7,000 |
| Net Non Operating Interest Income Expense | $-70,000 | $-69,000 | $-18,000 | $-574,000 |
| Interest Expense Non Operating | $159,000 | $69,000 | $18,000 | $574,000 |
| Operating Expense | $9,250,000 | $9,288,000 | $3,576,000 | $3,252,000 |
| Selling And Marketing Expense | $800,000 | $1,201,000 | $639,000 | $65,000 |
| General And Administrative Expense | $6,968,000 | $6,133,000 | $2,196,000 | $1,915,000 |
| Rent Expense Supplemental | - | - | - | $233,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-19,882,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Net Interest Income | $-70,000 | $-69,000 | $-18,000 | $-574,000 |
| Interest Income | $89,000 | $0 | - | - |
| Normalized Income | $-8,904,000 | $-9,441,000 | $-2,632,230 | $-3,819,000 |
| Net Income From Continuing And Discontinued Operation | $-19,882,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Total Operating Income As Reported | $-8,856,000 | $-10,054,000 | $-3,078,000 | $-3,329,000 |
| Net Income Common Stockholders | $-24,531,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Net Income | $-19,882,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Net Income Including Noncontrolling Interests | $-19,882,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Net Income Continuous Operations | $-19,882,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Pretax Income | $-19,877,000 | $-10,458,000 | $-2,602,000 | $-3,789,000 |
| Special Income Charges | $-1,604,000 | $-874,000 | $0 | $30,000 |
| Interest Income Non Operating | $89,000 | $0 | - | - |
| Operating Income | $-8,605,000 | $-9,180,000 | $-3,078,000 | $-3,252,000 |
| Gross Profit | $645,000 | $108,000 | $498,000 | $0 |
| Depreciation Amortization Depletion Income Statement | - | - | - | $0 |
| Depreciation And Amortization In Income Statement | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | - | $-1.60 | $-0.50 | $-0.73 |
| Basic EPS | - | $-1.60 | $-0.50 | $-0.73 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $7,770 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,568,000 | $-9,303,000 | $-2,621,000 | $-3,231,000 |
| Total Unusual Items | $-10,978,000 | $-1,019,000 | $37,000 | $30,000 |
| Total Unusual Items Excluding Goodwill | $-10,978,000 | $-1,019,000 | $37,000 | $30,000 |
| Reconciled Depreciation | $172,000 | $67,000 | $0 | $14,000 |
| EBITDA (Bullshit earnings) | $-19,546,000 | $-10,322,000 | $-2,584,000 | $-3,201,000 |
| EBIT | $-19,718,000 | $-10,389,000 | $-2,584,000 | $-3,215,000 |
| Diluted NI Availto Com Stockholders | $-24,531,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Otherunder Preferred Stock Dividend | $4,649,000 | $0 | - | - |
| Tax Provision | $5,000 | $2,000 | $1,000 | $0 |
| Other Special Charges | $1,353,000 | - | - | $59,000 |
| Impairment Of Capital Assets | $251,000 | $874,000 | $0 | $79,000 |
| Gain On Sale Of Security | $-9,374,000 | $-145,000 | $37,000 | - |
| Research And Development | $1,482,000 | $1,954,000 | $741,000 | $1,272,000 |
| Selling General And Administration | $7,768,000 | $7,334,000 | $2,835,000 | $1,980,000 |
| Other Gand A | $6,968,000 | $6,133,000 | $2,196,000 | $920,000 |
| Diluted Average Shares | - | $6,546,769 | $5,194,665 | $5,194,665 |
| Basic Average Shares | - | $6,546,769 | $5,194,665 | $5,194,665 |
| Gain On Sale Of Ppe | - | - | - | $166,000 |
| Write Off | - | - | - | $-2,000 |
| Rent And Landing Fees | - | - | - | $233,000 |
| Salaries And Wages | - | - | - | $762,000 |
Fetched: 2026-05-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,601,000 | $-555,000 | $-277,000 | $-2,111,000 |
| Total Assets | $10,477,000 | $4,601,000 | $2,641,000 | $135,000 |
| Total Non Current Assets | $6,450,000 | $1,973,000 | $386,000 | $52,000 |
| Non Current Prepaid Assets | $268,000 | $1,657,000 | $0 | $52,000 |
| Goodwill And Other Intangible Assets | $6,036,000 | $180,000 | $386,000 | $0 |
| Other Intangible Assets | $861,000 | $180,000 | $386,000 | - |
| Current Assets | $4,027,000 | $2,628,000 | $2,255,000 | $83,000 |
| Prepaid Assets | $978,000 | $697,000 | $28,000 | $6,000 |
| Inventory | $108,000 | $0 | - | - |
| Receivables | $194,000 | $121,000 | $84,000 | $19,000 |
| Accounts Receivable | $194,000 | $121,000 | $84,000 | - |
| Allowance For Doubtful Accounts Receivable | $-10,000 | $-112,000 | $-112,000 | - |
| Gross Accounts Receivable | $204,000 | $233,000 | $196,000 | - |
| Cash Cash Equivalents And Short Term Investments | $2,747,000 | $1,810,000 | $2,143,000 | $58,000 |
| Cash And Cash Equivalents | $2,747,000 | $1,810,000 | $2,143,000 | $58,000 |
| Cash Financial | - | $1,810,000 | $2,143,000 | - |
| Other Receivables | - | - | - | $19,000 |
| Debt | ||||
| Total Debt | - | $694,000 | - | - |
| Current Debt And Capital Lease Obligation | - | $694,000 | - | - |
| Current Debt | - | $694,000 | - | - |
| Other Current Borrowings | - | $694,000 | - | - |
| Net Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,840,000 | $4,976,000 | $2,532,000 | $2,246,000 |
| Total Non Current Liabilities Net Minority Interest | $21,000 | $0 | $0 | $0 |
| Non Current Deferred Liabilities | $21,000 | $0 | - | - |
| Current Liabilities | $2,819,000 | $4,976,000 | $2,532,000 | $2,246,000 |
| Other Current Liabilities | $478,000 | $827,000 | - | - |
| Current Deferred Liabilities | $228,000 | $13,000 | $0 | $909,000 |
| Payables And Accrued Expenses | $2,113,000 | $3,442,000 | $2,532,000 | $1,337,000 |
| Payables | $1,347,000 | $1,816,000 | $630,000 | $597,000 |
| Accounts Payable | $1,347,000 | $1,816,000 | $630,000 | $420,000 |
| Equity | ||||
| Common Stock Equity | $7,637,000 | $-375,000 | $109,000 | $-2,111,000 |
| Total Equity Gross Minority Interest | $7,637,000 | $-375,000 | $109,000 | $-2,111,000 |
| Stockholders Equity | $7,637,000 | $-375,000 | $109,000 | $-2,111,000 |
| Retained Earnings | $-111,615,000 | $-87,084,000 | $-76,624,000 | $-73,906,000 |
| Preferred Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $55,784 | - | - | - |
| Ordinary Shares Number | $13,964,367 | $8,122,060 | $8,122,060 | $7,870,251 |
| Share Issued | $14,020,151 | $8,122,060 | $8,122,060 | $7,870,251 |
| Tangible Book Value | $1,601,000 | $-555,000 | $-277,000 | $-2,111,000 |
| Invested Capital | $7,637,000 | $319,000 | $109,000 | $-2,111,000 |
| Working Capital | $1,208,000 | $-2,348,000 | $-277,000 | $-2,163,000 |
| Total Capitalization | $7,637,000 | $-375,000 | $109,000 | $-2,111,000 |
| Additional Paid In Capital | $119,251,000 | $86,709,000 | $76,733,000 | $71,776,000 |
| Capital Stock | $1,000 | $0 | $0 | $19,000 |
| Common Stock | $1,000 | $0 | $0 | $19,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $21,000 | $0 | - | - |
| Current Deferred Revenue | $228,000 | $13,000 | $0 | $909,000 |
| Current Accrued Expenses | $766,000 | $1,626,000 | $1,902,000 | $740,000 |
| Goodwill | $5,175,000 | $0 | - | - |
| Net PPE | $146,000 | $136,000 | $0 | $0 |
| Accumulated Depreciation | $-157,000 | $-12,000 | $0 | $-3,219,000 |
| Gross PPE | $303,000 | $148,000 | $0 | $3,219,000 |
| Other Properties | $271,000 | $148,000 | - | $2,716,000 |
| Machinery Furniture Equipment | $32,000 | - | - | $503,000 |
| Finished Goods | $0 | $0 | - | - |
| Work In Process | $0 | $0 | - | - |
| Raw Materials | $108,000 | $0 | - | - |
| Dueto Related Parties Current | - | - | - | $177,000 |
Fetched: 2026-05-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-8,322,000 | $-6,570,000 | $-2,558,000 | $-2,892,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-8,194,000 | $-6,155,000 | $-2,172,000 | $-2,892,000 |
| Cash Flow From Continuing Operating Activities | $-8,194,000 | $-6,155,000 | $-2,172,000 | $-2,892,000 |
| Operating Gains Losses | $10,722,000 | $156,000 | - | $-28,000 |
| Investing Activities | ||||
| Capital Expenditure | $-128,000 | $-415,000 | $-386,000 | - |
| Investing Cash Flow | $-2,488,000 | $-477,000 | $-386,000 | $262,000 |
| Cash Flow From Continuing Investing Activities | $-2,488,000 | $-477,000 | $-386,000 | $262,000 |
| Net Other Investing Changes | - | $-62,000 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $4,308,000 | $4,643,000 | $290,000 |
| Financing Cash Flow | $11,619,000 | $6,299,000 | $4,643,000 | $2,035,000 |
| Cash Flow From Continuing Financing Activities | $11,619,000 | $6,299,000 | $4,643,000 | $2,035,000 |
| Net Common Stock Issuance | $0 | $4,308,000 | $4,643,000 | $290,000 |
| Common Stock Issuance | $0 | $4,308,000 | $4,643,000 | $290,000 |
| Other | ||||
| Issuance Of Debt | $2,531,000 | $1,955,000 | $0 | $1,745,000 |
| Interest Paid Supplemental Data | $0 | $11,000 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,747,000 | $1,810,000 | $2,143,000 | $58,000 |
| Beginning Cash Position | $1,810,000 | $2,143,000 | $58,000 | $653,000 |
| Changes In Cash | $937,000 | $-333,000 | $2,085,000 | $-595,000 |
| Proceeds From Stock Option Exercised | $9,088,000 | $36,000 | $0 | - |
| Net Issuance Payments Of Debt | $2,531,000 | $1,955,000 | $0 | $1,745,000 |
| Net Short Term Debt Issuance | $2,531,000 | $1,955,000 | $0 | $1,745,000 |
| Short Term Debt Issuance | $2,531,000 | $1,955,000 | $0 | $1,745,000 |
| Net Business Purchase And Sale | $-2,360,000 | $0 | - | - |
| Purchase Of Business | $-2,360,000 | $0 | - | - |
| Net Intangibles Purchase And Sale | $0 | $-267,000 | $-386,000 | - |
| Net PPE Purchase And Sale | $-128,000 | $-148,000 | $0 | $262,000 |
| Purchase Of PPE | $-128,000 | $-148,000 | $0 | - |
| Change In Working Capital | $-1,182,000 | $445,000 | $136,000 | $391,000 |
| Change In Other Working Capital | $-44,000 | $13,000 | $-909,000 | $450,000 |
| Change In Payables And Accrued Expense | $-1,582,000 | $542,000 | $1,080,000 | $-98,000 |
| Change In Accrued Expense | $-952,000 | $-341,000 | $1,047,000 | $-18,000 |
| Change In Payable | $-630,000 | $883,000 | $33,000 | $-80,000 |
| Change In Account Payable | $-630,000 | $883,000 | $35,000 | $-80,000 |
| Change In Prepaid Assets | $509,000 | $-73,000 | $30,000 | $12,000 |
| Change In Inventory | $-37,000 | $0 | - | - |
| Change In Receivables | $-28,000 | $-37,000 | $-65,000 | $27,000 |
| Changes In Account Receivables | $-28,000 | $-37,000 | $-65,000 | - |
| Other Non Cash Items | $944,000 | $42,000 | - | $460,000 |
| Stock Based Compensation | $781,000 | $2,721,000 | $295,000 | $60,000 |
| Asset Impairment Charge | $251,000 | $874,000 | - | - |
| Depreciation Amortization Depletion | $172,000 | $67,000 | $0 | $14,000 |
| Depreciation And Amortization | $172,000 | $67,000 | $0 | $14,000 |
| Depreciation | $172,000 | $67,000 | $0 | $14,000 |
| Gain Loss On Investment Securities | $9,369,000 | $156,000 | - | - |
| Net Income From Continuing Operations | $-19,882,000 | $-10,460,000 | $-2,603,000 | $-3,789,000 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Sale Of Investment | - | - | - | $0 |
| Sale Of PPE | - | - | - | $262,000 |
| Gain Loss On Sale Of PPE | - | - | - | $-87,000 |
Fetched: 2026-05-24